Andrew Witty

Track

Insider profile

Currently holds a position at G1 Therapeutics Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director G1 Therapeutics Inc July 11, 2017 -
President, Chief Executive Officer of Optum UnitedHealth Group Inc Nov. 11, 2019 - April 20, 2020
Chief Executive Officer of Optum, Executive Vice President, Director UnitedHealth Group Inc July 1, 2018 - Nov. 11, 2019
Independent Director UnitedHealth Group Inc Aug. 4, 2017 - July 1, 2018
Andrew Witty's trades of UnitedHealth Group Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
141.51
Quantity 76,349 -36.1%
Value US$3,342,914
Transaction date
Proposed sale
Price
420.78
Quantity 42,542
Value US$1,661,523
Transaction date
Proposed sale
Price
487.49
Quantity 6,160
Value US$3,002,949
Transaction date
Planned sale
Price
527.90
Quantity 11,376 -12.9%
Value US$6,005,390
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-21 2023-07-19
PlS Planned sale
76,349 -36.1%
141.51
US$3,342,914 		76,349 -36.1% 141.51 US$3,342,914
2023-07-19 2023-07-19
PrS Proposed sale
42,542
420.78
US$1,661,523 		42,542 420.78 US$1,661,523
2023-05-01 2023-04-27
S Sale
61,605 +7.7%
222.10
US$373,141 		61,605 +7.7% 222.10 US$373,141
2023-04-27 2023-04-27
PrS Proposed sale
6,160
487.49
US$3,002,949 		6,160 487.49 US$3,002,949
2022-07-19 2022-07-18
PlS Planned sale
11,376 -12.9%
527.90
US$6,005,390 		11,376 -12.9% 527.90 US$6,005,390